Sort
8,912 grants matching “sars cov 2”
Emergent Properties of Complex Systems: From Atoms to Macromolecules; from Humans to Societies
$559,333Michael Levitt · Stanford University · R35 · FY2023 · GM
microRNA-controlled mRNA therapeutics
$559,205Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK
microRNA-controlled mRNA therapeutics
$559,205Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DK
Advancing Psychosocial and Biobehavioral Stress Measurement to Understanding Aging
$558,958Elissa S. Epel · University Of California, San Francisco · R24 · FY2021 · AG
Emergent Properties of Complex Systems: From Atoms to Macromolecules; from Humans to Societies
$558,519Michael Levitt · Stanford University · R35 · FY2025 · GM
Emergent Properties of Complex Systems: From Atoms to Macromolecules; from Humans to Societies
$558,519Michael Levitt · Stanford University · R35 · FY2024 · GM
Reverse-engineering a viral Swiss army knife: Crimean-Congo hemorrhagic fever virus glycoprotein functions in assembly, entry, and in vivo pathogenesis
$558,501Kartik Chandran · Albert Einstein College Of Medicine · R01 · FY2024 · AI
Vanderbilt CTU SARS-CoV-2 Supplement
$558,406David W Haas · Vanderbilt University Medical Center · UM1 · FY2020 · AI
Identification of allosteric molecules for DOR-KOR heteromer-mediated peripheral analgesia
$557,766William P Clarke · University Of Texas Hlth Science Center · R01 · FY2023 · DA
Evaluation of Operation Safer Ground: A Community-Level Rapid Housing Intervention for People Vulnerable to COVID-19.
$557,670Jennifer Lorvick · Research Triangle Institute · R01 · FY2023 · MD
Coordinated regeneration of lung epithelial and endothelial compartments
$557,634Andrew Vaughan · University Of Pennsylvania · R01 · FY2023 · HL
Role of IRE1 Alpha in Coronavirus Infections
$557,476Susan Leilani Fink · University Of Washington · R01 · FY2025 · AI
Automated, optimized, intelligent data collection for cryo-EM
$557,390Gabriel C Lander · Scripps Research Institute, The · R01 · FY2024 · GM
Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDS
$556,881Jun Yan · University Of Louisville · R01 · FY2025 · AI
Investigating the development and regulation of the extrafollicular B cell response as a programmed response type
$556,843Rebecca A Elsner · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Covid 19 cytokine storm
$556,406Sumant Singh Chugh · Rush University Medical Center · R01 · FY2024 · DK
Defining PRC2 complex epigenomic control in alveolar progenitor cells
$556,110William John Zacharias · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · HL
REACH-OUT (Research, Engagement and Action on COVID-19 Health Outcomes via Testing)
$556,041Matthew Wayne Decamp · University Of Colorado Denver · U01 · FY2022 · MD
Rational design and evaluation of novel mRNA vaccines against MERS-CoV
$554,964Lanying Du · Georgia State University · R01 · FY2021 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) - SARS-CoV-2 RELATED RESEARCH
$554,910Kevin Urdahl · Seattle Children'S Hospital · N01 · FY2020 · AI
Continued Support of an spf Macaca nemestrina breeding colony
$554,605Eric Kenneth Hutchinson · Johns Hopkins University · U42 · FY2021 · OD
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy
$553,964Calvin J Kuo · Stanford University · R01 · FY2020 · DK
Advancing immune organoid technology and organoid combinations
$553,826Mark M Davis · Stanford University · U19 · FY2024 · AI
Scaling and Sustaining COVID-19 Vaccination through Meaningful Community Engagement and Care Coordination for Underserved Communities
$553,710Nicole A Stadnick · University Of California, San Diego · R01 · FY2025 · MD
Automated, optimized, intelligent data collection for cryo-EM
$553,534Gabriel C Lander · Scripps Research Institute, The · R01 · FY2023 · GM